BRCA2

Let’s start with this: think of each person’s cancer as a unique locked door. Now imagine that with a simple test, we could find the right key to unlock that door and cure the cancer on the first try. This is the world of precision medicine, an emerging area of research that the Prostate Cancer Foundation (PCF) feels is the mechanism for finally unlocking the cancer problem. So what does this mean for patients? Consider Mark Meerschaert’s experience. In a matter of weeks, Mark went from being an active on-the-go professor to someone who could barely walk; metastatic prostate cancer had come from nowhere and spread throughout his body. As a respected mathematics professor and researcher,...
The much-contested question of whether or not a gene can be patented is under judicial scrutiny once again. The U.S. Supreme Court listened to oral arguments today regarding Myriad Genetic’€™s patent of two genes, BRCA1 and BRCA2, which have been linked to increased cancer risk in both women and men. The American Civil Liberties Union is challenging this patent on behalf of a group of researchers, medical groups and patients. The timing of the hearing is rather serendipitous, just one day after the 10 th anniversary of the completion of the Human Genome Project. The Human Genome Project, a jointly funded venture from the Department of Energy and the National Institutes of Health, has opened...

Sidebar Quote

Funding research gives all of us a better chance of living a healthier life.
Pam Hirata, heart disease survivor